Tortolero-Luna G - Search Results

1

Association between adiponectin, insulin resistance, and endometrial cancer.

Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH. Soliman PT, et al. Cancer. 2006 Jun 1;106(11):2376-81. doi: 10.1002/cncr.21866. Cancer. 2006. PMID: 16639730 Free article.

2

Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes.

Chuang L, Burke TW, Tornos C, Marino BD, Mitchell MF, Tortolero-Luna G, Levenback C, Morris M, Gershenson DM. Chuang L, et al. Gynecol Oncol. 1995 Aug;58(2):189-93. doi: 10.1006/gyno.1995.1208. Gynecol Oncol. 1995. PMID: 7622103

3

Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread.

Marino BD, Burke TW, Tornos C, Chuang L, Mitchell MF, Tortolero-Luna G, Morris M, Gershenson DM. Marino BD, et al. Gynecol Oncol. 1995 Jan;56(1):34-8. doi: 10.1006/gyno.1995.1006. Gynecol Oncol. 1995. PMID: 7821845

4

Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma.

Burke TW, Gershenson DM, Morris M, Stringer CA, Levenback C, Tortolero-Luna G, Baker VV. Burke TW, et al. Gynecol Oncol. 1994 Oct;55(1):47-50. doi: 10.1006/gyno.1994.1245. Gynecol Oncol. 1994. PMID: 7959265 Clinical Trial.

5

Chemoprevention trials and surrogate end point biomarkers in the cervix.

Mitchell MF, Hittelman WK, Lotan R, Nishioka K, Tortolero-Luna G, Richards-Kortum R, Wharton JT, Hong WK. Mitchell MF, et al. Cancer. 1995 Nov 15;76(10 Suppl):1956-77. doi: 10.1002/1097-0142(19951115)76:10+<1956::aid-cncr2820761312>3.0.co;2-v. Cancer. 1995. PMID: 8634987 Review.

6

Endometrial hyperplasia and endometrial cancer.

Burke TW, Tortolero-Luna G, Malpica A, Baker VV, Whittaker L, Johnson E, Follen Mitchell M. Burke TW, et al. Obstet Gynecol Clin North Am. 1996 Jun;23(2):411-56. Obstet Gynecol Clin North Am. 1996. PMID: 8784886 Review.

7

Ovarian intraepithelial neoplasia and ovarian cancer.

Gershenson DM, Tortolero-Luna G, Malpica A, Baker VV, Whittaker L, Johnson E, Follen Mitchell M. Gershenson DM, et al. Obstet Gynecol Clin North Am. 1996 Jun;23(2):475-543. Obstet Gynecol Clin North Am. 1996. PMID: 8784888 Review.

8

Molecular profile of advanced-stage transitional cell carcinoma of the ovary.

Gershenson DM, Baker VV, Price JE, Hung MC, El-Naggar AK, Tortolero-Luna G, Silva EG. Gershenson DM, et al. Am J Obstet Gynecol. 1997 Jul;177(1):120-5. doi: 10.1016/s0002-9378(97)70449-6. Am J Obstet Gynecol. 1997. PMID: 9240594

9

Serous borderline tumors of the ovary with noninvasive peritoneal implants.

Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tornos C. Gershenson DM, et al. Cancer. 1998 Nov 15;83(10):2157-63. doi: 10.1002/(sici)1097-0142(19981115)83:10<2157::aid-cncr14>3.0.co;2-d. Cancer. 1998. PMID: 9827720

10

Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.

Gershenson DM, Deavers M, Diaz S, Tortolero-Luna G, Miller BE, Bast RC Jr, Mills GB, Silva EG. Gershenson DM, et al. Clin Cancer Res. 1999 Dec;5(12):4053-8. Clin Cancer Res. 1999. PMID: 10632339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters